Epion Therapeutics

Developer of minimally-invasive treatments for corneal ectatic diseases

placeBurlington, Massachusetts, United States calendar_todayFounded 2012 language epiontx.com

Innovation

5 patent families (4 granted) — focus: Human necessities; filing pace active. Cited 509 times.

YearFilings
20243
20253

Investor mix

1 investor on record; lead investors include AXA Investment Managers.

Investor typeCountShare
Bank & private debt1100%
Coming soon